Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Baillie Gifford -International Growth. This analysis is provided for institutional research purposes only and is not investment advice.
"Baillie Gifford's International Growth Strategy focuses on exceptional growth companies despite recent geopolitical volatility. Chinese holdings like BYD and Pinduoduo outperformed while semiconductors faced cyclical weakness."
Baillie Gifford's International Growth Strategy maintains its focus on long-term ownership of exceptional growth companies despite recent market volatility driven by geopolitical tensions. The strategy targets companies that can either grow rapidly and disrupt industries or compound growth at exceptional rates over time. Recent performance has been mixed, with Chinese names like Pinduoduo, Wuxi Bio, and BYD performing strongly, while semiconductor holdings like ASML faced cyclical weakness viewed as temporary noise. Spotify delivered excellent results by balancing cost reduction with business reinvestment. The team made strategic adjustments, adding positions in Galderma and Disco while reducing exposure to Genmab due to patent expiration concerns and trimming SMC for insufficient growth prospects. Portfolio turnover has been elevated but is expected to normalize. Despite trade war concerns, management remains optimistic about international opportunities, noting that 85% of global trade occurs outside the US. The strategy emphasizes patient capital deployment, focusing on operational performance and growth potential relative to valuation while maintaining discipline during volatile periods.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
Conviction is moderate (0.65) because the strategy is relatively diversified, holding at least 50 positions. However, they express strong beliefs in specific holdings and have taken decisive sizing actions, such as halving underperformer Genmab and adding to WiseTech and Galderma.
Growth Outlook
The manager maintains a positive but measured outlook (0.75), noting that while markets have been nervous due to geopolitics and trade wars, 85% of global trade occurs outside the US, leaving international growth managers well-positioned.
Risk Appetite
The strategy shows a healthy risk appetite (0.75), continuing to invest in volatile sectors like semiconductors and adding to positions on weakness, while maintaining high equity exposure.
Capital Deployment
Capital deployment is moderately active (0.75) as they have actively funded new buys like Galderma and Disco by selling SMC and taking profits in Spotify.
Forward Guidance
Forward guidance is scored at 0.75 as the team is selectively adding new ideas from a full research pipeline, although they expect turnover to normalize back down to the 10-20% range.
Language Signal
The language signal (0.70) is net positive, dominated by constructive terms like 'excited', 'terrific business', 'great growth prospects', and 'going great guns', offset by 'disappointment' and 'bumpy'.
Perceived Risk
Perceived risk is moderate (0.60), reflecting awareness of macro-level trade war tensions and geopolitical shifts, which they believe represent real economic reshaping but are manageable for adaptable businesses.
Opportunity Density
The manager sees a rich opportunity set (0.75), describing a full research pipeline with many new ideas being discussed and a deliberate effort to broaden the investment funnel.
Time Horizon
The strategy is anchored on an exceptionally long-term time horizon (0.90), explicitly aiming to be multi-year compounders of growth and frequently referencing 10-year outlooks.
